2018Frontiers in Cardiovascular MedicineOpen access

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility

Matthew Chin, Christopher Johns, Benjamin J. Currie, Nicholas Weatherley, Catherine Hill, Charlie Elliot, Smitha Rajaram, Jim M. Wild, Robin Condliffe, Stephen Bianchi, David G. Kiely, Andrew J. Swift

Open full text 44 citations

Abstract

Purpose It is postulated that ILD causes PA dilatation independent of the presence of pulmonary hypertension (PH), so the use of PA size to screen for PH is not recommended. The aims of this study were to investigate the association of PA size with the presence and severity of ILD and to assess the diagnostic accuracy of PA size for detecting PH. Methods Incident patients referred to a tertiary PH centre underwent baseline thoracic computed tomography (CT), magnetic resonance imaging (MRI) and right heart catheterisation (RHC). Pulmonary artery diameter was measured on CT pulmonary angiography and pulmonary arterial areas on MRI. A thoracic radiologist scored the severity of ILD on CT from 0–4, 0=absent, 1=1–25%, 2=26–50%, 3=51–75%, and 4=76–100% extent of involvement. Receiver operating characteristic analysis and linear regression were employed to assess diagnostic accuracy and independent associations of PA size. Results 110 had suspected PH due to ILD (age 65 years (SD 13), M:F 37:73) and 379 had suspected PH without ILD (age 64 years (SD 13), M:F 161:218). CT derived main PA diameter was accurate for detection of PH in patients both with and without ILD - AUC 0.873, p=<0.001, and AUC 0.835, p=<0.001, respectively, as was MRI diastolic PA area, AUC 0.897, p=<0.001, and AUC 0.857, p=<0.001, respectively Significant correlations were identified between mean pulmonary arterial pressure (mPAP) and PA diameter in ILD (r = 0.608, P < 0.001), and non-ILD cohort (r = 0.426, P <0.001). PA size was independently associated with mPAP (p<0.001) and BSA (p=0.001), but not with Forced vital capacity % predicted (p=0.597), Transfer factor of the lungs for carbon monoxide (TLCO) % predicted (p=0.321) or the presence of ILD on CT (p=0.905). The severity of ILD was not associated with pulmonary artery dilatation (r = 0.071, p = 0.459). Conclusions Pulmonary arterial pressure elevation leads to pulmonary arterial dilation, which is not independently influenced by the presence or severity of ILD measured by FVC, TLCO, or disease severity on CT. Pulmonary arterial diameter has diagnostic value in patients with or without ILD and suspected PH.

Open-access reader

About this research paper

What this paper is about

Purpose It is postulated that ILD causes PA dilatation independent of the presence of pulmonary hypertension (PH), so the use of PA size to screen for PH is not recommended. The aims of this study were to investigate the association of PA size with the presence and severity of ILD and to assess the diagnostic accuracy of PA size for detecting PH. Methods Incident patients referred to a tertiary PH centre underwent baseline thoracic computed tomography (CT), magnetic resonance imaging (MRI) and right heart catheterisation (RHC). Pulmonary artery diameter was measured on CT pulmonary angiography and pulmonary arterial areas on MRI. A thoracic radiologist scored the severity of ILD on CT from 0–4, 0=absent, 1=1–25%, 2=26–50%, 3=51–75%, and 4=76–100% extent of involvement. Receiver operating characteristic analysis and linear regression were employed to assess diagnostic accuracy and independent associations of PA size. Results 110 had suspected PH due to ILD (age 65 years (SD 13), M:F 37:73) and 379 had suspected PH without ILD (age 64 years (SD 13), M:F 161:218). CT derived main PA diameter was accurate for detection of PH in patients both with and without ILD - AUC 0.873, p=<0.001, and AUC 0.835, p=<0.001, respectively, as was MRI diastolic PA area, AUC 0.897, p=<0.001, and AUC 0.857, p=<0.001, respectively Significant correlations were identified between mean pulmonary arterial pressure (mPAP) and PA diameter in ILD (r = 0.608, P < 0.001), and non-ILD cohort (r = 0.426, P <0.001). PA size was independently associated with mPAP (p<0.001) and BSA (p=0.001), but not with Forced vital capacity % predicted (p=0.597), Transfer factor of the lungs for carbon monoxide (TLCO) % predicted (p=0.321) or the presence of ILD on CT (p=0.905). The severity of ILD was not associated with pulmonary artery dilatation (r = 0.071, p = 0.459). Conclusions Pulmonary arterial pressure elevation leads to pulmonary arterial dilation, which is not independently influenced by the presence or severity of ILD measured by FVC, TLCO, or disease severity on CT. Pulmonary arterial diameter has diagnostic value in patients with or without ILD and suspected PH.

Why it matters

OpenAlex reports 44 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Purpose It is postulated that ILD causes PA dilatation independent of the presence of pulmonary hypertension (PH), so the use of PA size to screen for PH is not recommended. The aims of this study were to investigate the association of PA size with the presence and severity of ILD and to assess the diagnostic accuracy of PA size for detecting PH. Methods Incident patients referred to a tertiary PH centre underwent baseline thoracic computed tomography (CT), magnetic resonance imaging (MRI) and right heart catheterisation (RHC). Pulmonary artery diameter was measured on CT pulmonary angiography and pulmonary arterial areas on MRI. A thoracic radiologist scored the severity of ILD on CT from 0–4, 0=absent, 1=1–25%, 2=26–50%, 3=51–75%, and 4=76–100% extent of involvement. Receiver operating characteristic analysis and linear regression were employed to assess diagnostic accuracy and independent associations of PA size. Results 110 had suspected PH due to ILD (age 65 years (SD 13), M:F 37:73) and 379 had suspected PH without ILD (age 64 years (SD 13), M:F 161:218). CT derived main PA diameter was accurate for detection of PH in patients both with and without ILD - AUC 0.873, p=<0.001, and AUC 0.835, p=<0.001, respectively, as was MRI diastolic PA area, AUC 0.897, p=<0.001, and AUC 0.857, p=<0.001, respectively Significant correlations were identified between mean pulmonary arterial pressure (mPAP) and PA diameter in ILD (r = 0.608, P < 0.001), and non-ILD cohort (r = 0.426, P <0.001). PA size was independently associated with mPAP (p<0.001) and BSA (p=0.001), but not with Forced vital capacity % predicted (p=0.597), Transfer factor of the lungs for carbon monoxide (TLCO) % predicted (p=0.321) or the presence of ILD on CT (p=0.905). The severity of ILD was not associated with pulmonary artery dilatation (r = 0.071, p = 0.459). Conclusions Pulmonary arterial pressure elevation leads to pulmonary arterial dilation, which is not independently influenced by the presence or severity of ILD measured by FVC, TLCO, or disease severity on CT. Pulmonary arterial diameter has diagnostic value in patients with or without ILD and suspected PH.

Key concepts: Medicine, Interstitial lung disease, Pulmonary hypertension, Pulmonary artery, Cardiology, Internal medicine, Lung, Cohort

Related papers

Back to paper searchBrowse research topicsOriginal source
Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility — Research Paper | ScholarLens